1. Tell us about RPRD diagnostics and what is the focus of your company?
2. You use the term “Preemptive Pharmacogenomics.” What is this? What are its benefits?
3. You offer the product DMET as a CLIA certified test, will you do the same for PharmacoScan?
4. Why is HLA analysis important for pharmacogenomics?
5. RPRD diagnostics will offer PharmacoScan as a service, what should customers expect in terms of the output product?